{"filing":{"accession_number":"0001193125-26-263724","cik":"0001691082","ticker":"LBRX","company_name":"LB PHARMACEUTICALS INC","form":"8-K","filing_date":"2026-06-09","report_date":null,"primary_document":"d138757d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1691082/000119312526263724/d138757d8k.htm"},"events":[{"id":4360,"run_id":3811,"accession_number":"0001193125-26-263724","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a classic Item 5.07 disclosure reporting the final results of the Company's 2026 Annual Meeting of Stockholders held on June 3, 2026. The filing presents voting tallies for two proposals: election of three Class I directors (Robert A. Lenz, Rebecca Luse, and Ran Nussbaum) and ratification of BDO USA, P.C. as independent auditor. All proposals passed with substantial majorities. Shareholder vote results are material to investors as they confirm board composition and auditor appointment.","company_name":"LB PHARMACEUTICALS INC","ticker":"LBRX","filing_date":"2026-06-09","items":[{"id":5486,"accession_number":"0001193125-26-263724","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the final results of the Company's 2026 Annual Meeting of Stockholders held on June 3, 2026. The filing presents voting tallies for two proposals: election of three Class I directors (Robert A. Lenz, Rebecca Luse, and Ran Nussbaum) and ratification of BDO USA, P.C. as independent auditor. All proposals passed with substantial majorities. Shareholder vote results are material to investors as they confirm board composition and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T20:06:11.015098+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5486,"accession_number":"0001193125-26-263724","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a classic Item 5.07 disclosure reporting the final results of the Company's 2026 Annual Meeting of Stockholders held on June 3, 2026. The filing presents voting tallies for two proposals: election of three Class I directors (Robert A. Lenz, Rebecca Luse, and Ran Nussbaum) and ratification of BDO USA, P.C. as independent auditor. All proposals passed with substantial majorities. Shareholder vote results are material to investors as they confirm board composition and auditor appointment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-09T20:06:11.015098+00:00","company_name":"LB PHARMACEUTICALS INC","ticker":"LBRX","filing_date":"2026-06-09"}]}